Positron (POSC) Stock Price, News & Analysis

Company Overview

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Key Stats

• Today's Range: $1.80 to $1.80
• 50-Day Range: $1.65 to $1.97
• 52-Week Range: $1.25 to $2.74
• Volume: 8,365 shs
• Average Volume: 68,695 shs
• Market Capitalization: $59.13 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Positron Stock Analysis - MarketRank™

Positron scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Positron.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Positron is -5.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Positron is -5.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Positron has been sold short.

Short Interest Ratio / Days to Cover

Positron has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Positron has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Positron does not currently pay a dividend.

Dividend Growth

Positron does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Positron this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Positron insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.20% of the stock of Positron is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Positron has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/15/2026
• Today: 5/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:POSC
• CIK: 844985
• Web: www.positron.com
• Phone: (317) 576-0183
• Fax: 630-537-1249
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.33)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.60 million
• Net Margins: -1,996.75%
• Pretax Margin: -2,001.72%
• Return on Equity: -996.81%
• Return on Assets: -272.52%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.87
• Quick Ratio: 0.59

Sales & Book Value

• Annual Sales: $460 thousand
• Price / Sales: 128.54
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 32,850,000
• Free Float: 27,196,000
• Market Cap: $59.13 million
• Optionable: Not Optionable
• Beta: 0.15